Paul Tudor Jones II's position in Chemed is currently worth $4.26 Million. That's 0.05% of their equity portfolio (433rd largest holding). The first Chemed trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares nine more times and sold shares on eleven occasions. The stake costed the investor $3.94 Million, netting the investor a gain of 8.3% so far.